Similar Articles
471 Current status of adjuvant chemotherapy for gastric cancer
472 Tumor progression-dependent angiogenesis in gastric cancer and its potential application
473 MicroRNA-331 inhibits development of gastric cancer through targeting musashi1
474 Association of XPG rs2094258 polymorphism with gastric cancer prognosis
475 High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients
476 shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway
477 Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer
478 HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
479 Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice
480 Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA